ArticleAnnals of translational medicine2020

To combine or not to combine: anti-vascular endothelial growth factor therapies in EGFR mutation positive non-small cell lung cancer.

Hidehito HorinouchiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.